Moreover, high expression of IL-6R was significantly correlated with tamoxifen resistance in these ER+ breast cancer cases (p = 0.005 Mann–Whitney U test), as well as by chi-square test (p = 1.9 × 10−5) (Figure 6C). The gene discussed is IL6R; the disease is breast carcinoma.